Form 8-K - Current report:
SEC Accession No. 0001193125-25-172653
Filing Date
2025-08-04
Accepted
2025-08-04 16:31:30
Documents
13
Period of Report
2025-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17349d8k.htm   iXBRL 8-K 28983
2 EX-99.1 d17349dex991.htm EX-99.1 8349
  Complete submission text file 0001193125-25-172653.txt   157093

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20250801.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20250801_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20250801_pre.xml EX-101.PRE 11274
16 EXTRACTED XBRL INSTANCE DOCUMENT d17349d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 251180826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)